Insider Transactions in Q3 2022 at Invitae Corp (NVTA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 25
2022
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,350
-0.53%
|
$4,050
$3.45 P/Share
|
|
Aug 22
2022
|
Robert L Nussbaum Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,000
+10.7%
|
-
|
|
Aug 22
2022
|
Robert F. Werner Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,000
+17.61%
|
-
|
|
Aug 22
2022
|
Yafei Wen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
102,000
+18.6%
|
-
|
|
Aug 22
2022
|
Thomas Brida |
BUY
Grant, award, or other acquisition
|
Direct |
54,000
+10.93%
|
-
|
|
Aug 16
2022
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,048
-1.75%
|
$28,192
$4.55 P/Share
|
|
Aug 16
2022
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,252
-1.61%
|
$13,008
$4.55 P/Share
|
|
Aug 16
2022
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
22,085
-2.72%
|
$88,340
$4.55 P/Share
|
|
Aug 16
2022
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
7,048
-1.79%
|
$28,192
$4.55 P/Share
|
|
Jul 17
2022
|
Sean E George Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,050
+1.94%
|
-
|
|
Jul 16
2022
|
Randal W. Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
53,800
+22.02%
|
-
|